Consun Pharmaceutical Group Ltd

01681

Company Profile

  • Business description

    Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

  • Contact

    71, Dongpeng Avenue
    Eastern section
    Guangzhou Economic and Technological Development
    Guangzhou
    CHN

    T: +86 2082264529

    https://www.chinaconsun.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    3,073

Stocks News & Analysis

stocks

Market too pessimistic about unloved ASX health care share

Our analysts believe a long-term margin recovery is underway.
stocks

Two overvalued ASX shares to avoid

Both shares trade at a significant premium to our fair value.
stocks

Materially undervalued ASX tech share

Long reinvestment runway supports our thesis on ASX technology company.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,899.306.50-0.07%
CAC 408,093.1967.390.84%
DAX 4023,703.09238.461.02%
Dow JONES (US)47,434.96322.510.68%
FTSE 1009,694.2984.760.88%
HKSE25,928.0833.530.13%
NASDAQ23,211.13185.540.81%
Nikkei 22549,559.07899.551.85%
NZX 50 Index13,562.0181.580.61%
S&P 5006,814.5948.710.72%
S&P/ASX 2008,606.509.50-0.11%
SSE Composite Index3,864.185.84-0.15%

Market Movers